RS61155B1 - Transdermalni terapijski sistem za davanje aktivne supstance - Google Patents

Transdermalni terapijski sistem za davanje aktivne supstance

Info

Publication number
RS61155B1
RS61155B1 RS20201478A RSP20201478A RS61155B1 RS 61155 B1 RS61155 B1 RS 61155B1 RS 20201478 A RS20201478 A RS 20201478A RS P20201478 A RSP20201478 A RS P20201478A RS 61155 B1 RS61155 B1 RS 61155B1
Authority
RS
Serbia
Prior art keywords
administering
active substance
therapeutic system
transdermal therapeutic
transdermal
Prior art date
Application number
RS20201478A
Other languages
English (en)
Inventor
Britta Langer
Bjoern Schurad
Heike Prinz
Original Assignee
Luye Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luye Pharma Ag filed Critical Luye Pharma Ag
Publication of RS61155B1 publication Critical patent/RS61155B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
RS20201478A 2010-12-14 2011-12-14 Transdermalni terapijski sistem za davanje aktivne supstance RS61155B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10194968.3A EP2468274B1 (de) 2010-12-14 2010-12-14 Transdermales therapeutisches System zur Verabreichung eines Wirkstoffs
PCT/EP2011/072812 WO2012080365A1 (de) 2010-12-14 2011-12-14 Transdermales therapeutisches system zur verabreichung eines wirkstoffs
EP11799413.7A EP2651410B1 (de) 2010-12-14 2011-12-14 Transdermales therapeutisches system zur verabreichung eines wirkstoffs

Publications (1)

Publication Number Publication Date
RS61155B1 true RS61155B1 (sr) 2020-12-31

Family

ID=43836835

Family Applications (2)

Application Number Title Priority Date Filing Date
RS20150562A RS54173B1 (sr) 2010-12-14 2010-12-14 Transdermalni terapijski sistem za davanje aktivne supstance
RS20201478A RS61155B1 (sr) 2010-12-14 2011-12-14 Transdermalni terapijski sistem za davanje aktivne supstance

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RS20150562A RS54173B1 (sr) 2010-12-14 2010-12-14 Transdermalni terapijski sistem za davanje aktivne supstance

Country Status (24)

Country Link
US (2) US10660863B2 (sr)
EP (2) EP2468274B1 (sr)
JP (1) JP6043296B2 (sr)
KR (1) KR101842309B1 (sr)
CN (3) CN107412202A (sr)
AU (2) AU2011343363B2 (sr)
CA (2) CA2817461C (sr)
CY (2) CY1116638T1 (sr)
DK (2) DK2468274T3 (sr)
EA (1) EA026520B1 (sr)
ES (2) ES2545094T3 (sr)
HK (1) HK1243336A1 (sr)
HR (2) HRP20150881T1 (sr)
HU (2) HUE027916T2 (sr)
LT (1) LT2651410T (sr)
MX (1) MX345344B (sr)
MY (1) MY183873A (sr)
PL (2) PL2468274T3 (sr)
PT (2) PT2468274E (sr)
RS (2) RS54173B1 (sr)
SI (2) SI2468274T1 (sr)
SM (1) SMT201500184B (sr)
WO (1) WO2012080365A1 (sr)
ZA (1) ZA201303965B (sr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012000369A1 (de) * 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
DE102012016317A1 (de) 2012-08-14 2014-02-20 Jenabatteries GmbH Redox-Flow-Zelle zur Speicherung elektrischer Energie
US20150196515A1 (en) * 2012-08-15 2015-07-16 Dow Coming Corporation Multi-Layer Drug Delivery System
WO2014111790A2 (en) * 2013-01-15 2014-07-24 Zydus Technologies Limited Stable transdermal pharmaceutical drug delivery system comprising rivastigmine
CN109640976B (zh) 2016-08-22 2023-10-17 救急药品工业株式会社 贴附剂
EP3656383A4 (en) * 2017-07-19 2021-05-19 Teikoku Seiyaku Co., Ltd. RIVASTIGMIN-CONTAINING PERCUTICAL ABSORPTION PREPARATION
DE102018120505A1 (de) * 2017-10-20 2019-04-25 Amw Gmbh Verhinderung der Kristallisation von Wirkstoffen in transdermalen Darreichungssystemen
DE102017127433A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices
CA3092757A1 (en) * 2018-03-13 2019-09-19 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system comprising a silicone acrylic hybrid polymer
WO2019220697A1 (ja) * 2018-05-17 2019-11-21 パナソニックＩｐマネジメント株式会社 生体貼付け用選択透過膜、経皮吸収キットおよび美容方法
EP3513965B1 (en) 2018-08-08 2022-05-04 Danapak Flexibles A/S Improved films and laminates for use in packaging reactive compounds
KR20200025883A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
KR20200025888A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
WO2021005118A1 (en) * 2019-07-09 2021-01-14 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system comprising an active agent-containing layer comprising an acrylic polymer and a skin contact layer comprising a silicone gel adhesive
CN113616625B (zh) * 2021-08-26 2023-05-30 大连科翔科技开发有限公司 一种卡巴拉汀的长效透皮贴剂

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201906B (en) 1987-03-04 1991-01-28 Sandoz Ag Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them
EP0656771A4 (en) * 1992-08-25 1996-07-31 Cygnus Therapeutic Systems DEVICE FOR TRANSDERMAL DRUG DELIVERY.
JPH0912448A (ja) * 1995-04-28 1997-01-14 Read Chem Kk 薬物放出制御型経皮吸収製剤
GB9800526D0 (en) * 1998-01-12 1998-03-11 Ciba Geigy Ag Organic compounds
US6348210B1 (en) * 1998-11-13 2002-02-19 Alza Corporation Methods for transdermal drug administration
DE19918106A1 (de) * 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
DE10033853A1 (de) 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
DE10103860B4 (de) * 2001-01-30 2004-12-23 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
DE10141652B4 (de) 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
US8252319B2 (en) * 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
SI1814531T1 (sl) * 2004-10-21 2010-10-29 Durect Corp Transdermalni dostavni sistem
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
CN101351233A (zh) * 2005-12-30 2009-01-21 科洛普拉斯特公司 具有可塑的层作为皮肤接触表面的层状粘合构造
CN101304735A (zh) * 2006-01-12 2008-11-12 Lts勒曼治疗系统股份公司 用于挥发性和/或热不稳定的物质的经皮治疗体系
WO2007129427A1 (ja) * 2006-05-08 2007-11-15 Teikoku Seiyaku Co., Ltd. 抗認知症薬物の経皮吸収製剤
US9248104B2 (en) * 2006-08-17 2016-02-02 Core Tech Solutions, Inc. Transdermal methods and systems for treating Alzheimer's disease
DE102006054731B4 (de) * 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
EP2167001A4 (en) 2007-07-10 2012-10-31 Agile Therapeutics Inc THERMAL DELIVERY DEVICE WITH ULTRASONIC WELDING
WO2009026135A2 (en) * 2007-08-17 2009-02-26 Alza Corporation Controlled transdermal bisoprolol delivery system
ES2661767T3 (es) * 2008-02-27 2018-04-03 Hisamitsu Pharmaceutical Co., Inc. Parche adhesivo para la piel y producto envasado
US20090291127A1 (en) * 2008-05-21 2009-11-26 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
JP2010126450A (ja) * 2008-11-25 2010-06-10 Lintec Corp 経皮吸収貼付剤
US8962014B2 (en) * 2009-12-22 2015-02-24 Acino Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof

Also Published As

Publication number Publication date
JP6043296B2 (ja) 2016-12-14
EP2468274B1 (de) 2015-07-01
KR101842309B1 (ko) 2018-03-26
EA201300704A1 (ru) 2014-01-30
AU2011343363B2 (en) 2017-06-08
ES2545094T3 (es) 2015-09-08
SI2468274T1 (sl) 2015-10-30
AU2011343363A1 (en) 2013-06-20
US10660863B2 (en) 2020-05-26
MY183873A (en) 2021-03-17
WO2012080365A1 (de) 2012-06-21
US20200289426A1 (en) 2020-09-17
AU2017213569A1 (en) 2017-08-31
AU2017213569B2 (en) 2019-04-11
CA2817461C (en) 2020-02-25
DK2468274T3 (en) 2015-08-31
CN103269698A (zh) 2013-08-28
HUE027916T2 (en) 2016-11-28
US20140323996A1 (en) 2014-10-30
CY1116638T1 (el) 2017-03-15
EP2651410B1 (de) 2020-10-14
PL2651410T3 (pl) 2021-03-08
CN103269698B (zh) 2017-07-14
EP2468274A1 (de) 2012-06-27
HRP20150881T1 (hr) 2015-09-25
ZA201303965B (en) 2014-09-25
HK1243336A1 (zh) 2018-07-13
PL2468274T3 (pl) 2015-11-30
CA3065240A1 (en) 2012-06-21
CN113244199A (zh) 2021-08-13
EA026520B1 (ru) 2017-04-28
CY1123712T1 (el) 2022-03-24
EP2651410A1 (de) 2013-10-23
CA2817461A1 (en) 2012-06-21
BR112013014616A2 (pt) 2016-09-20
DK2651410T3 (da) 2020-11-02
SMT201500184B (it) 2015-09-07
LT2651410T (lt) 2020-12-28
HUE052137T2 (hu) 2021-04-28
RS54173B1 (sr) 2015-12-31
ES2836483T3 (es) 2021-06-25
HRP20201880T1 (hr) 2021-02-05
MX345344B (es) 2017-01-26
PT2651410T (pt) 2020-12-15
PT2468274E (pt) 2015-09-21
SI2651410T1 (sl) 2021-01-29
KR20130129988A (ko) 2013-11-29
JP2014503523A (ja) 2014-02-13
CN107412202A (zh) 2017-12-01
CA3065240C (en) 2022-02-15
MX2013005581A (es) 2013-08-26

Similar Documents

Publication Publication Date Title
ZA201303965B (en) Transdermal therapeutic system for administering an active substance
EP2560624A4 (en) THERAPEUTIC FORMULATION TO REDUCE THE SIDE EFFECTS OF MEDICATION
EP2726141A4 (en) DEVICE, SYSTEM AND METHODS FOR ORAL DELIVERY OF THERAPEUTIC COMPOUNDS
EP2792746A4 (en) OLIGONUCLEOTIDE AND THERAPEUTIC FOR HYPERLIPIDEMIA WITH THIS AS AN ACTIVE SUBSTANCE
PT2515886T (pt) Sistema terapêutico transdermal para a administração de rivastigmina ou de seus derivados
EP2526986A4 (en) DEVICE FOR THE ADMINISTRATION OF MEDICINAL PRODUCTS
EP2720748A4 (en) TRANSDERMAL DRUG DELIVERY SYSTEM AND METHOD OF USE THEREOF
EP2911747A4 (en) ACTIVE SOIL FOR PROTON THERAPY
HK1215787A1 (zh) 用於治療疼痛的藥物組合
PL2616133T3 (pl) Aparaty do podawania leków przez skórę
EP2755712A4 (en) SYSTEM FOR ANCHORING MEDICAL DEVICES
HK1182015A1 (zh) 活性藥物化合物用於治療中樞神經系統病症的用途
EP2538913A4 (en) Device and system for determining, preparing and administering therapeutically effective doses
ZA201403497B (en) Transdermal therapeutic system for administering fentanyl or analogue thereof
ZA201301458B (en) Therapeutic agent for pain
AP3390A (en) Therapeutic vaccination against active tuberculosis
EP2525823A4 (en) DELIVERY SYSTEM FOR DIAGNOSTIC AND THERAPEUTIC AGENTS
HK1179906A1 (zh) 用於經由血管內輸注來施用治療劑的裝置
EP2548580A4 (en) PHARMACEUTICAL FOR PSEUDOTRAINING THERAPY
EP2485719A4 (en) TRANSDERMAL THERAPEUTIC SYSTEM
SI2566579T1 (sl) Medicinska naprava za magnetoterapijo